CliffBio
small molecule

ROXYBOND

OXYCODONE HYDROCHLORIDE

Loss of exclusivityAugust 2028latest FDA-listed patent expiry
CompanyPROTEGA PHARMACEUTICALS INC

Drug detail

Brand nameROXYBOND
Active ingredientOXYCODONE HYDROCHLORIDE
Strength30MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalApril 2017
Marketing statusRX

Listed patents

PatentExpiresType
10314788August 2028product
7955619August 2028product

More from PROTEGA PHARMACEUTICALS INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ROXYBOND patent cliff — loss of exclusivity August 2028 | CliffBio